Blanco-Heredia, Juan http://orcid.org/0000-0001-9526-7450
Souza, Carla Anjos http://orcid.org/0000-0003-0671-7275
Trincado, Juan L. http://orcid.org/0000-0001-5363-3774
Gonzalez-Cao, Maria http://orcid.org/0000-0003-3791-540X
Gonçalves-Ribeiro, Samuel http://orcid.org/0000-0002-0261-3965
Gil, Sara Ruiz
Pravdyvets, Dmytro
Cedeño, Samandhy http://orcid.org/0000-0001-8312-0208
Callari, Maurizio http://orcid.org/0000-0001-5239-0918
Marra, Antonio
Gazzo, Andrea M.
Weigelt, Britta http://orcid.org/0000-0001-9927-1270
Pareja, Fresia http://orcid.org/0000-0003-3748-8049
Vougiouklakis, Theodore
Jungbluth, Achim A.
Rosell, Rafael http://orcid.org/0000-0003-0817-3400
Brander, Christian http://orcid.org/0000-0002-0548-5778
Tresserra, Francesc
Reis-Filho, Jorge S. http://orcid.org/0000-0003-2969-3173
Tiezzi, Daniel Guimarães http://orcid.org/0000-0002-2660-0093
de la Iglesia, Nuria http://orcid.org/0000-0002-1083-7715
Heyn, Holger http://orcid.org/0000-0002-3276-1889
De Mattos-Arruda, Leticia http://orcid.org/0000-0002-4992-3645
Article History
Received: 21 August 2023
Accepted: 19 January 2024
First Online: 21 February 2024
Competing interests
: L.D.M.A. has received honoraria for participation in a speaker’s bureau/ consultancy from Roche and reports research collaboration and support from NanoString Technologies, Education grant: BMS, Lilly. L.D.M.A. is currently employed by BioNTech SE. H.H. is co-founder and shareholder of Omniscope, SAB member of Nanostring and MiRXES, and consultant to Moderna and Singularity. C.A.S. is a scientific associate of Dataomics Biotech. J.B.H. is currently affiliated with the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. J.S.R.-F. reports receiving personal/consultancy fees from Goldman Sachs, Bain Capital, REPARE Therapeutics, Saga Diagnostics, MultiplexDX, and Paige.AI, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics and Paige.AI, membership of the Board of Directors of Grupo Oncoclinicas, and ad hoc membership of the scientific advisory boards of AstraZeneca, Merck, Daiichi Sankyo, Roche Tissue Diagnostics and Personalis, outside the scope of this study. J.S.R.-F. is currently employed by AstraZeneca. B.W. reports research funding from Repare Therapeutics, outside the scope of the submitted work. The other authors declare no competing interests.